PRS-211096

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePRS-211096
Drug Alias NamePRS-211,096
ClassificationOther
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsPainAutoimmune DiseasesNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmos Corp
Active IndicationsN/A
Inactive IndicationsPainAutoimmune DiseasesNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A